How much is Palamedrix worth in 2026?

Palamedrix has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Palamedrix raised?

Palamedrix has raised N/A in total funding across 1 funding rounds.

Palamedrix

Biotechnology

Palamedrix valuation and funding history | Last updated: January 1, 2020 | 1 funding rounds

Current Valuation

N/A

As of January 1, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

Amount undisclosed

Last Funding

Jan 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2020	Seed Round	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Palamedrix is currently valued at N/A as of January 1, 2020.

Track Palamedrix Valuation Updates

Get notified when Palamedrix raises new funding or valuation changes

Explore More Data

Detailed analysis for Palamedrix

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Palamedrix's valuation history, funding rounds, and growth metrics.

No credit card required

What is Palamedrix Worth in 2026?

Palamedrix is a leading private company in the Biotechnology sector. Track Palamedrix's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Palamedrix Valuation is Determined

Private company valuations like Palamedrix's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.